Health and Fitness Health and Fitness
Mon, December 8, 2008
[ Mon, Dec 08th 2008 ] - Market Wire
Updated Data Evaluating Clinical Benefit Of REVLI .. /Refractory Aggressive Non-Hodgkins Lymphoma Pres
[ Mon, Dec 08th 2008 ] - Market Wire
Vein Clinics of America Opens New Location in Monroeville, Pa
[ Mon, Dec 08th 2008 ] - Market Wire
IntelliDOT Corporation: Seventeen Additional Heal .. itals Go Live With IntelliDOT Corporation's Barco
[ Mon, Dec 08th 2008 ] - Market Wire
ERBITUX Supplemental Biologics License Applicati .. ll Lung Cancer Submitted to U.S. Food and Drug Ad
[ Mon, Dec 08th 2008 ] - Market Wire
Acusphere, Inc. Announces Posting of Briefing Doc .. nal Drugs Advisory Committee Meeting on Imagify "
[ Mon, Dec 08th 2008 ] - Market Wire
GlaxoSmithKline: FDA Approves GlaxoSmithKline Tet .. , Whooping Cough Vaccine, BOOSTRIX(R), for Adults
[ Mon, Dec 08th 2008 ] - Market Wire
Idera Pharmaceuticals to Present at 10th Annual Massachusetts Biotechnology Investors Forum
[ Mon, Dec 08th 2008 ] - Market Wire
Somatic Systems, Inc.: Somatic Systems, Inc. Tele .. and Airdates to December National Broadcast Sched
[ Mon, Dec 08th 2008 ] - Market Wire
Dynavax Presents Preclinical Data Supporting Its Novel Universal Flu Vaccine Candidate
[ Mon, Dec 08th 2008 ] - Market Wire
Bio-Imaging Technologies Partners with AG Mednet .. fer Complete Imaging Solution for Clinical Trials
[ Mon, Dec 08th 2008 ] - Market Wire
Zwei ASH-Pr sentationen berichten ber Aktivit t .. REVLIMID bei Patienten mit nicht vorbehandelter
[ Mon, Dec 08th 2008 ] - Market Wire
Molecular Insight Pharmaceuticals, Inc. to Presen .. at 2008 RBC Capital Markets Healthcare Conference
[ Mon, Dec 08th 2008 ] - Market Wire
Bard Receives FDA Approval for the E Luminexx " Vascular Stent
[ Mon, Dec 08th 2008 ] - Market Wire
Scientists Report that T 4 May Have Important Role in Multiple Myeloma
[ Mon, Dec 08th 2008 ] - Market Wire
Neoprobe Achieves Final Milestone in $13 Million .. sitive Phase 3 Breast Cancer and Melanoma Results
[ Mon, Dec 08th 2008 ] - Market Wire
Monogram Announces Presentations to be made at the CTRC-AACR San Antonio Breast Cancer Symposium
[ Mon, Dec 08th 2008 ] - Market Wire
Ligand Presents Positive LGD-4665 Clinical Trial .. theAmerican Society of Hematology Annual Meeting
[ Mon, Dec 08th 2008 ] - Market Wire
SeraCare Reports Fourth Quarter and Full Fiscal Year 2008 Results
[ Mon, Dec 08th 2008 ] - Market Wire
BioSante Pharmaceuticals Signs Elestrin " Marketing Agreement with PharmaSwiss SA for Israel
[ Mon, Dec 08th 2008 ] - Market Wire
Orthofix International Reports Previously-Filed False Claims Act Complaint is Unsealed
[ Mon, Dec 08th 2008 ] - Market Wire
Data from Pivotal Study Show Medtronic Deep Brain .. ced Seizure Rate in Patients with Severe Epilepsy
[ Mon, Dec 08th 2008 ] - Market Wire
DOR BioPharma, Inc.: DOR BioPharma Announces FDA .. learance of IND for DOR201 in Radiation Enteritis
[ Mon, Dec 08th 2008 ] - Market Wire
ZIOPHARM Presents Positive Darinaparsin Phase II Data at ASH Meeting
[ Mon, Dec 08th 2008 ] - Market Wire
Bristol-Myers Squibb and AstraZeneca Announce Exp .. tion to Develop and Commercialize Dapagliflozin i
[ Mon, Dec 08th 2008 ] - Market Wire
Premier Cooperative Group in Adult Lymphoma Resea .. ajor Study in Disease s Largest Patient Populati
[ Mon, Dec 08th 2008 ] - Market Wire
Importante gruppo cooperativo di ricerca nel linf .. IMID per uno studio di primaria importanza condo
[ Mon, Dec 08th 2008 ] - Market Wire
Cypress Bioscience, Inc.: Cypress Bioscience, Inc .. sent at RBC Capital Markets Healthcare Conference
[ Mon, Dec 08th 2008 ] - Market Wire
VIVUS To Participate in Obesity Panel at the 2008 RBC Capital Markets Healthcare Conference
[ Mon, Dec 08th 2008 ] - Market Wire
Cytori Demonstrates Benefit of Adipose-Derived St .. Cells in Spinal Disc Repair in Preclinical Study
[ Mon, Dec 08th 2008 ] - Market Wire
Emergent BioSolutions to Webcast Presentation at .. ealthcare Conference on Wednesday, January 14, 20

Emergent BioSolutions to Webcast Presentation at the J.P. Morgan 27th Annual Healthcare Conference on Wednesday, January 14, 20


Published on 2008-12-08 04:55:07 - Market Wire
  Print publication without navigation


ROCKVILLE, Md.--([ BUSINESS WIRE ])--Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the J.P. Morgan 27th Annual Healthcare Conference scheduled for Wednesday January 14, 2009 at 8:30 am Pacific. A member of the company's senior management team will provide a corporate overview, including a discussion of product development programs, recent corporate activities and financial performance.

A webcast of this presentation will be available both live and by replay. To access either the live or archived webcast, please proceed to [ www.emergentbiosolutions.com ], and click on the "Investors" link the day of the presentation.

An archived replay of the webcast will be available 24 hours after the live presentation.

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a leading biopharmaceutical company dedicated to one simple mission—to protect life. Emergent develops, manufactures and commercializes immune-related biologics, vaccines and biotherapeutics that assist the body's immune system to prevent or treat infectious and other life threatening diseases. Emergent's marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. Emergent's clinical pipeline includes programs focused on anthrax, botulism, typhoid, tuberculosis, hepatitis B and chlamydia. [ www.emergentbiosolutions.com ].

Contributing Sources